Daniel J. Lippis, CVP, JAPAC at Edwards Lifesciences Corp (EW), sold 2,500 shares at $74.08 ($185K) on 2024-12-16, disclosed to the SEC on 2024-12-16.
Scheduled sale ($185k) by CVP, JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |
| EW | SELL | 2026-05-18 | $50K | — | Filing → |